● Recruiting

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Condition: Cardiovascular Diseases · Sponsor: Jung-min Ahn

PhasePhase 4

Planned participants5000

Who can joinAll sexes, 40 Years to 75 Years

Healthy volunteersNo

About this study

The primary objective of the ASA-3C trial is to evaluate the role of aspirin and high-intensity statin therapy, respectively, in individuals with severe coronary calcification (coronary calcium score ≥300) to prevent atherosclerotic cardiovascular disease (ASCVD) events with severe coronary calcification (CAC ≥300).

This description comes directly from the study's public registry record.

Talk to the study team

Jung-min Ahn, MD · 82230104728 · drjmahn@gmail.com

Always discuss trial participation with your own doctor first.

Locations (32)

Hallym University Medical Center	Anyang, South Korea	Not Yet Recruiting
SAM hospital	Anyang, South Korea	Not Yet Recruiting
Sejong General Hospital	Bucheon-si, South Korea	Recruiting
Dong-A University Hospital	Busan, South Korea	Not Yet Recruiting
Haeundae paik hospital, inje university	Busan, South Korea	Recruiting
Inje University Busan Paik Hospital	Busan, South Korea	Recruiting
Gyeongsang National University Changwon Hospital	Changwon, South Korea	Recruiting
Chungbuk National University Hospital	Cheonju, South Korea	Recruiting
Hallym University Chuncheon Sacred Heart Hospital	Chuncheon, South Korea	Not Yet Recruiting
Kangwon National University Hospital	Chuncheon, South Korea	Recruiting
Keimyung University Dongsan Medical Center	Daegu, South Korea	Recruiting
Kyungpook National University Hospital	Daegu, South Korea	Recruiting

+ 20 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06676280